Career Possibilities Panel & Speed Networking - Clinical, Regulatory, Patient Outcomes, & Analytical Development

In the world of business, careers are no longer linear or predictable. What was once a clearly sign-posted path as you progressed through milestones, a career road map is now circuitous presenting new challenges and opportunities at every bend. Life-long careers in one sector or one company are becoming a rarity as new technologies and shifting social norms disrupt traditional careers. Both employers and employees are seeking more diversity of experience, lifestyle flexibility and alternative paths.

This panel is designed to help you think about your career path and the different options that are open to you. The panel will have an informational interview type feel with panelists sharing their career paths, a look at what their job entails, transferrable skills for those looking to make a change, tips for uncovering opportunities, advice for others, and how to make brave leaps.  The panel will be moderated by Siennah Greenfield, Principal Scientist, DMPK, Pfizer.

Panelists will include:

  • Erin Comerford, Global Health Economics & Value Assessment Business Partner, Oncology, Sanofi
  • Elvis Osei Tutu, Vice President, Head of Regulatory Affairs, Fusion Pharmaceuticals
  • Joanna Pearson, Associate Director Patient Education Liaison Team Lead, Rare Disease Education, Alnylam Pharmaceutics
  • Sarah Rush, Director of R&D, Concentric by Ginkgo
  • Janaki (Jana) M. Subramanyam, Vice President, Head of Regulatory Affairs, Abcuro, Inc. 


Date and Time:  
October 17, 2023
6:00-7:30 PM EST

4 mins: Welcome
60 mins: Panel discussion
12 mins: Small group speed networking
2 mins: Learnings
12 mins: Small group speed networking



Register Here


Thanks to Our Series Sponsor!



Panelist Bios:

Erin Comerford received her master’s degree in epidemiology from the Harvard T.H. Chan School of Public Health and a bachelor’s degree in biostatistics from UNC Chapel Hill. She works at Sanofi as a Director of Health Economics & Value Assessment and facilitates access to new oncology products for patients around the world. In her current role, Erin is responsible for setting and executing the payer evidence generation plan for an investigational lung cancer drug. In addition to the safety and efficacy of new products, payers and health technology assessments require an understanding of the humanistic, economic, and clinical value a new medicine brings. HEOR/HEVA professionals generate and communicate such data in partnership with cross-functional teams like Medical Affairs and Market Access. Prior to Sanofi, Erin held positions in health tech at Aetion and Noona. Outside the office, Erin enjoys running along the Charles River in Cambridge, salsa dancing, and trying new restaurants.

Elvis Osei Tutu is currently the Vice President, Head of Regulatory Affairs at Fusion Pharmaceuticals. In this role, he leads a team of Regulatory professionals who oversee the development of Global regulatory strategies for Fusion’s pipeline of radiopharmaceutical products. Prior to joining Fusion, he previously served as the Vice President, Head of Regulatory Affairs at Magenta Therapeutics and at Checkmate Pharmaceuticals. Elvis also previously worked at Abbvie, GlaxoSmithKline (GSK), and Bristol Myers Squibb (BMS), where he held roles of increasing responsibilities. Elvis is a highly experienced and respected regulatory professional. Throughout his career, he has overseen the development and approval of several drugs for different indications. Elvis has a Bachelors degree in Biochemistry, a Doctor of Pharmacy, and completed a 2 year post-doctoral fellowship in Regulatory Affairs. He also holds the Regulatory Affairs Certification (RAC).

Joanna Pearson, BSN RN I have been a Registered Nurse for 20 years and am so happy that I made the decision to go to work with my mother one day in 1990 and be introduced to the field of nursing. I am currently a Patient Education Liaison Team Lead (East) for a team of nurse educators that provide education to patients, families and communities about several rare and ultra rare liver diseases. I live in Ohio (Go Bucks!) and graduated for Ohio University in 2004 with my associates degree in nursing then went back to school in 2015 and obtained my Bachelor’s degree in nursing. During my career I have worked in multiple specialties (i.e. Hospice, Medsurg, and Neurology, Marketing) and the main theme that I loved in all of my roles was the patient education and being a resource of information for the patients and their families. I have been with Alnylam Pharmaceuticals for the past 5 years and have had the great pleasure of working with some amazing people, scientists, and patients. As well as being able to be my authentic self and bring my passion for educating to the role. I was able to exhibit my leadership skills as an individual contributor, and ultimately was promoted to my current role this year 2023. I have been married to my high school sweetheart for 27 years, we have 3 adult sons and 3 grandchildren (who call me Yaya).  

Sarah Rush is well-versed in many areas of biotechology. Ms. Rush’s breadth and depth of experience includes research in cancer, neurodevelopment, biofuels, personal care, and bioanalytical services. Her projects have ranged from early phase discovery to late-phase product development, frequently implementing novel approaches to meet project and customer requirements. In addition, she has leveraged her expertise to evaluate technical risk, market trends, and customer behaviors to design a balanced project portfolio. Ms. Rush’s technical background is in analytical biochemistry and she has progressed into roles that span technical, operational, and business responsibilities. She is currently a Director of R&D at Concentric by Ginkgo, the biosecurity unit of Ginkgo Bioworks.

Janaki (Jana) M. Subramanyam, MS, RAC is Vice President, Head of Regulatory Affairs at Abcuro, Inc., a biotechnology company focused on precision targeting of cytotoxic T-cells in autoimmune diseases. In this role, Jana leads and develops regulatory strategies for the global development of ABC008, an afucosylated monoclonal antibody. Jana’s career spans almost 30 years in Regulatory Affairs in the industry with successful approvals for both drugs & biologics in the US & Europe. Her career began in Discovery & Preclinical Research before she made a career change to Regulatory Affairs. Prior to joining Abcuro, Jana was the Head of Regulatory Affairs at Allena Pharmaceuticals, Inc. where she helped develop two assets for rare metabolic diseases. Jana also held leadership roles in regulatory affairs at FORUM Pharmaceuticals, Lantheus Medical Imaging, and AMAG Pharmaceuticals. She received her M.S. in Microbiology from Ohio University, Athens, OH and her B.S. in Microbiology and Biochemistry from Bombay University, India.